Ground Swell Capital LLC Takes $450,000 Position in The Cooper Companies, Inc. (NASDAQ:COO)

Ground Swell Capital LLC acquired a new stake in The Cooper Companies, Inc. (NASDAQ:COO) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 5,339 shares of the medical device company’s stock, valued at approximately $450,000. Cooper Companies accounts for 1.0% of Ground Swell Capital LLC’s holdings, making the stock its 25th biggest holding.

Several other institutional investors and hedge funds have also made changes to their positions in COO. Zions Bancorporation National Association UT acquired a new position in shares of Cooper Companies during the 1st quarter worth about $33,000. City Holding Co. purchased a new stake in Cooper Companies during the 1st quarter valued at approximately $34,000. GKV Capital Management Co. Inc. purchased a new stake in Cooper Companies during the 1st quarter valued at approximately $40,000. Covestor Ltd raised its stake in Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company’s stock valued at $42,000 after acquiring an additional 120 shares during the last quarter. Finally, Larson Financial Group LLC raised its stake in Cooper Companies by 1,071.0% during the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company’s stock valued at $61,000 after acquiring an additional 664 shares during the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have issued reports on the company. UBS Group upgraded Cooper Companies to a “buy” rating in a research report on Tuesday, June 17th. Loop Capital set a $100.00 target price on Cooper Companies in a report on Tuesday, June 17th. Needham & Company LLC upgraded Cooper Companies from a “hold” rating to a “buy” rating and set a $94.00 target price on the stock in a report on Tuesday, June 17th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $76.00 price target (down previously from $110.00) on shares of Cooper Companies in a research note on Friday, May 30th. Finally, Mizuho reduced their price target on Cooper Companies from $105.00 to $90.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 16th. Three investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Cooper Companies presently has an average rating of “Moderate Buy” and an average price target of $96.73.

Cooper Companies Trading Up 2.2%

NASDAQ:COO opened at $74.27 on Thursday. The business’s 50-day moving average is $71.86 and its two-hundred day moving average is $79.46. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.10 and a quick ratio of 1.23. The Cooper Companies, Inc. has a 12 month low of $65.00 and a 12 month high of $112.38. The firm has a market capitalization of $14.85 billion, a PE ratio of 36.05, a price-to-earnings-growth ratio of 1.77 and a beta of 1.00.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.03. The company had revenue of $1 billion during the quarter, compared to the consensus estimate of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The company’s revenue was up 6.3% on a year-over-year basis. During the same period last year, the firm earned $0.85 earnings per share. Research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.